Stock Award Plans and Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands					3 Months Ended		6 Months Ended	9 Months Ended
	Aug. 01, 2024 $ / shares	Jun. 12, 2024 $ / shares	Mar. 12, 2024 shares	Mar. 11, 2024 shares	Sep. 30, 2023 shares	Jun. 30, 2023 shares	Jun. 30, 2024 USD ($)	Sep. 30, 2024 USD ($) incentive_plan shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of incentive plans | incentive_plan								3
Exercise price limit (percent)								100.00%
Exercise price limit for individuals owning over ten percent (percent)								110.00%
Unrecognized compensation expense related to unvested awards | $								$ 6,400
Weighted average remaining term								1 year 11 months 8 days
Common stock issued to Xeriant, Inc. (in shares)					3,142	12,853
Non-Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $								$ 240
Non-Executive Officer | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued to Xeriant, Inc. (in shares)			46,265
Scott Pomeroy | Chief Executive Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $								1,900
Scott Pomeroy | Chief Executive Officer | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, shares issued (in shares)			357,039
Maxim Group LLC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $							$ 2,030
Maxim Group LLC | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued to Xeriant, Inc. (in shares)			385,359
Chardan Capital Markets
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment charges | $								$ 1,000
Chardan Capital Markets | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued to Xeriant, Inc. (in shares)			189,036
Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, expiration period								10 years
Vesting period								4 years
Two Thousand Seventeen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, expiration period								10 years
Shares available for future grant (in shares)								0
Share-based payment arrangement, option inducement, net exercised into common shares (in shares)			92,728
Two Thousand Seventeen Plan | Inpixon
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, option inducement, net exercised into common shares (in shares)				1,038,871
Two Thousand Eighteen Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future grant (in shares)								0
Vesting period	3 years	3 years
2018 Plan aggregate number of options authorized (in shares)								67,148,179
Aggregate number of shares available for future grant under stock option plan (in shares)								52,370,064
Stock option exercise price (in usd per share) | $ / shares	$ 0.473	$ 0.473
Two Thousand Eighteen Plan | Share-based Payment Arrangement, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		33.30%
Two Thousand Eighteen Plan | Share-based Payment Arrangement, Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		33.30%
Two Thousand Eighteen Plan | Share-based Payment Arrangement, Tranche Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting rights, percentage		33.30%